Impact of switching to long-acting injectable antipsychotics on health services use in the treatment of schizophrenia

Canadian journal of psychiatry. Revue canadienne de psychiatrie

Volumn 60, Issue 3, 2015, Pages S40-S47

  Lachaine, Jean ^a   Lapierre, Marie Eve ^a   Abdalla, Nadine ^a   Rouleau, Alice ^a   Stip, Emmanuel ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DELAYED RELEASE FORMULATION; NEUROLEPTIC AGENT;

ADULT; DELAYED RELEASE FORMULATION; ECONOMICS; FEMALE; HOSPITALIZATION; HUMAN; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PATIENT ATTITUDE; PSYCHOTIC DISORDERS; QUEBEC; SCHIZOPHRENIA; STATISTICS AND NUMERICAL DATA; THERAPEUTIC USE;

ADULT; ANTIPSYCHOTIC AGENTS; DELAYED-ACTION PREPARATIONS; FEMALE; HOSPITALIZATION; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PSYCHOTIC DISORDERS; QUEBEC; SCHIZOPHRENIA;

EID: 85018208393     PISSN: None     EISSN: 14970015     Source Type: Journal    
DOI: None     Document Type: Article

References (0)